Bhatt, M.D., M.P.H., Martin B. Leon, M.D.D.: Feasible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.. Raj R. Makkar, M.D., Gregory Fontana, M.D., Hasan Jilaihawi, M.D., Tarun Chakravarty, M.D., Klaus F. Kofoed, M.D., D.M.Sc., Ole de Backer, M.D., Ph.D., Federico M. Asch, M.D., Carlos E. Ruiz, M.D., Niels T. Olsen, M.D., Ph.D., Alfredo Trento, M.D., John Friedman, M.D., Daniel Berman, M.D., Wen Cheng, M.D., Mohammad Kashif, M.D., Vladimir Jelnin, M.D., Chad A.They discovered that during a median follow-up of 19 months, individuals monitored with gene-expression profiling, as compared with those that underwent routine biopsies, experienced similar two-year cumulative rates of the composite major outcome. The two-year prices of all-cause mortality were also equivalent in the gene-expression profiling and biopsy arms. Patients in the gene-expression profiling group underwent one-sixth the amount of biopsies per person-calendar year of follow-up compared with sufferers in the biopsy group. Related StoriesScalable creation of gene therapy vectors: an interview with Frank UbagsDeaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHMEHow feasible is usually telesurgery? The CARGO-research, whose lead writer was Dr.